DE69738452D1 - Fusionspolypeptide die eine ige-bindungsdomäne und eine hsa-komponente enthalten und deren diagnostische und therapeutische verwendung - Google Patents

Fusionspolypeptide die eine ige-bindungsdomäne und eine hsa-komponente enthalten und deren diagnostische und therapeutische verwendung

Info

Publication number
DE69738452D1
DE69738452D1 DE69738452T DE69738452T DE69738452D1 DE 69738452 D1 DE69738452 D1 DE 69738452D1 DE 69738452 T DE69738452 T DE 69738452T DE 69738452 T DE69738452 T DE 69738452T DE 69738452 D1 DE69738452 D1 DE 69738452D1
Authority
DE
Germany
Prior art keywords
diagnostic
binding domain
fusion polypeptides
therapeutic uses
polypeptides containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738452T
Other languages
English (en)
Other versions
DE69738452T2 (de
Inventor
Mary Ellen Digan
Philip Lake
Hermann Gram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE69738452D1 publication Critical patent/DE69738452D1/de
Publication of DE69738452T2 publication Critical patent/DE69738452T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69738452T 1996-07-26 1997-07-25 Fusionspolypeptide die eine ige-bindungsdomäne und eine hsa-komponente enthalten und deren diagnostische und therapeutische verwendung Expired - Lifetime DE69738452T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69021696A 1996-07-26 1996-07-26
PCT/EP1997/004066 WO1998004718A1 (en) 1996-07-26 1997-07-25 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
US690216 2000-10-17

Publications (2)

Publication Number Publication Date
DE69738452D1 true DE69738452D1 (de) 2008-02-21
DE69738452T2 DE69738452T2 (de) 2008-12-24

Family

ID=24771594

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738452T Expired - Lifetime DE69738452T2 (de) 1996-07-26 1997-07-25 Fusionspolypeptide die eine ige-bindungsdomäne und eine hsa-komponente enthalten und deren diagnostische und therapeutische verwendung

Country Status (28)

Country Link
EP (1) EP0917581B1 (de)
JP (1) JP3681402B2 (de)
KR (1) KR100502879B1 (de)
CN (1) CN1146664C (de)
AR (1) AR008077A1 (de)
AT (1) ATE383429T1 (de)
AU (1) AU722069B2 (de)
BR (1) BR9710605A (de)
CA (1) CA2261562C (de)
CO (1) CO4650184A1 (de)
CZ (1) CZ297634B6 (de)
DE (1) DE69738452T2 (de)
ES (1) ES2300114T3 (de)
HK (1) HK1020352A1 (de)
ID (1) ID19420A (de)
IL (2) IL128094A0 (de)
MY (1) MY120425A (de)
NO (1) NO323611B1 (de)
NZ (1) NZ333908A (de)
PE (1) PE99498A1 (de)
PL (1) PL189415B1 (de)
PT (1) PT917581E (de)
RU (1) RU2209211C2 (de)
SK (1) SK7799A3 (de)
TR (1) TR199900155T2 (de)
TW (1) TW565571B (de)
WO (1) WO1998004718A1 (de)
ZA (1) ZA976666B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056471A4 (de) * 1998-01-29 2001-05-30 Tanox Inc BEHANDLUNG ATOPISCHER DERMATITIS MIT IgE ANTAGONISTEN
JP4087563B2 (ja) 1998-06-15 2008-05-21 ジーティーシー バイオセラピューティックス インコーポレイテッド エリスロポエチン類似体−ヒト血清アルブミン融合物
EP1208194A2 (de) * 1999-08-09 2002-05-29 Genaissance Pharmaceuticals, Inc. Isogene arzneimittel-ziele: polymorphismen des gens der immunglobulin e rezeptor i alpha untereinheit
DE10026998A1 (de) * 2000-05-31 2001-12-13 Fresenius Kabi De Gmbh Verfahren zur Herstellung einer kosmetischen Zusammensetzung, die humanes Serum Albumin umfasst, welches aus transgenen nicht-menschlichen Säugern erhalten wurde
IL155812A0 (en) * 2000-12-07 2003-12-23 Lilly Co Eli Glp-1 fusion proteins
TW200526779A (en) * 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
EP1463751B1 (de) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Albuminfusionsproteine
US8927694B2 (en) 2008-11-18 2015-01-06 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof
US8962274B2 (en) 2009-02-27 2015-02-24 Novartis Ag Methods for selecting eukaryotic cells expressing a heterologous protein
WO2012169735A2 (ko) * 2011-06-07 2012-12-13 (주)네오팜 FCεRI의 수용성 단편을 포함하는 복합체 및 이를 포함하는 IGE 매개 알레르기성 질환 치료용 조성물
RU2506271C2 (ru) * 2011-06-22 2014-02-10 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) РЕКОМБИНАНТНЫЙ ПОЛИПЕПТИД А2, СЕЛЕКТИВНО СВЯЗЫВАЮЩИЙ HSA, РЕКОМБИНАНТНАЯ ДНК pa2, КОДИРУЮЩАЯ HSA-СВЯЗЫВАЮЩУЮ ЧАСТЬ ПОЛИПЕПТИДА A2, ЕГО ПРОДУЦЕНТ - РЕКОМБИНАНТНЫЙ ШТАММ Escherichia coli M15-A2, СОДЕРЖАЩИЙ РЕКОМБИНАНТНУЮ ПЛАЗМИДНУЮ ДНК pQE 32-pa2, ОБЕСПЕЧИВАЮЩУЮ ПОЛУЧЕНИЕ ПОЛИПЕПТИДА A2 И ПРИМЕНЕНИЕ ПОЛИПЕПТИДА А2 ДЛЯ ДИАГНОСТИКИ МИКРОАЛЬБУМИНУРИИ И ВЫДЕЛЕНИЯ HSA ИЗ СЫВОРОТКИ КРОВИ
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents
US20180139938A1 (en) * 2015-05-04 2018-05-24 Laboratoire Français du Fractionnement et des, Biotechnologies Transgenic production of fc fusion proteins
EP3192806A1 (de) 2016-01-13 2017-07-19 Affiris AG Alpha-kette des hochaffinen ige-rezeptors (fceria)
JP7127859B2 (ja) * 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
EP3998277A4 (de) * 2019-07-08 2023-11-22 Progen Co., Ltd. Neuartige il-10-proteinvariante und ihre verwendung
CN111773392B (zh) * 2020-05-25 2023-04-07 河南省生物工程技术研究中心 一种人血白蛋白/寡核苷酸纳米颗粒及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
GB8909916D0 (en) * 1989-04-29 1989-06-14 Delta Biotechnology Ltd Polypeptides
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies

Also Published As

Publication number Publication date
KR100502879B1 (ko) 2005-07-25
DE69738452T2 (de) 2008-12-24
KR20000029563A (ko) 2000-05-25
PT917581E (pt) 2008-04-11
AR008077A1 (es) 1999-12-09
EP0917581B1 (de) 2008-01-09
MY120425A (en) 2005-10-31
HK1020352A1 (en) 2000-04-14
IL128094A (en) 2006-08-20
WO1998004718A1 (en) 1998-02-05
NO323611B1 (no) 2007-06-18
BR9710605A (pt) 1999-08-17
CO4650184A1 (es) 1998-09-03
ES2300114T3 (es) 2008-06-01
JP2000516089A (ja) 2000-12-05
ZA976666B (en) 1999-01-25
TW565571B (en) 2003-12-11
JP3681402B2 (ja) 2005-08-10
PE99498A1 (es) 1999-01-21
EP0917581A1 (de) 1999-05-26
ATE383429T1 (de) 2008-01-15
CZ24699A3 (cs) 1999-04-14
IL128094A0 (en) 1999-11-30
CN1229439A (zh) 1999-09-22
AU722069B2 (en) 2000-07-20
CA2261562C (en) 2011-04-05
PL331356A1 (en) 1999-07-05
NZ333908A (en) 1999-10-28
TR199900155T2 (xx) 2000-08-21
AU4202597A (en) 1998-02-20
NO990328D0 (no) 1999-01-25
CN1146664C (zh) 2004-04-21
RU2209211C2 (ru) 2003-07-27
ID19420A (id) 1998-07-09
NO990328L (no) 1999-02-19
SK7799A3 (en) 1999-07-12
PL189415B1 (pl) 2005-08-31
CA2261562A1 (en) 1998-02-05
CZ297634B6 (cs) 2007-02-21

Similar Documents

Publication Publication Date Title
DE69738452D1 (de) Fusionspolypeptide die eine ige-bindungsdomäne und eine hsa-komponente enthalten und deren diagnostische und therapeutische verwendung
DE69706948D1 (de) Weichlotwerkstoff und dessen Verwendung in ein elektronisches Bauteil
DE69821463D1 (de) Polypropylenharzzusammensetzung und deren verwendung
DE69422048D1 (de) Tintenstrahlaufzeichnungsverfahren und aufzeichnungsmaterial
DE69031783D1 (de) Bildaufzeichnungsmaterial und Bildaufzeichnungsverfahren damit
DE69526969D1 (de) Thermoplastische harzzusammensetzung und seine verwendung
DE69806925T2 (de) Ligand-aminodextran-markierungsubstanzkonjugate und deren verwendung
DE69729149D1 (de) Prozesskassette und Bilderzeugungsgerät mit herausnehmbarer Prozesskassette
DE69634122D1 (de) Heterocyclische amidverbindungen und deren medizinische verwendung
DE69718839D1 (de) Informationsaufzeichnungsverfahren und Vorrichtung mit Zusatzaufzeichnungsfunktion
KR900009914A (ko) 근적외선 흡광제 및 이를 이용하여 제조된 표시/기록 물질
DE59506234D1 (de) Pigmentzubereitung und deren Verwendung
DE69631240D1 (de) Schaltvorrichtung und deren verwendung
DE69416363D1 (de) Abbildendes festkörperbauteil und herstellungsverfahren dafür
DE59802439D1 (de) Spiroverbindungen und deren verwendung
DE69401392D1 (de) Polypropylen-Harzzusammensetzung und seine Verwendung
DE69632678D1 (de) Harzzusammensetzung und deren verwendung
DE69817432D1 (de) Cycloolefinpolymere und deren Verwendung
DE69713512D1 (de) Substituierte phtalocyanine und deren verwendung
DE69431415T2 (de) Kondensator mit drei Anschlüssen und Bauteil mit diesem Kondensator
DE69519821T2 (de) Pulverförmiges Material zur Verwendung beim Wiederstandsschweissen von Aluminiumgegenständen und Wiederstandsschweissen von Aluminiumgegenständen
DE69431350D1 (de) Vergiessbares canola-öl und dessen verwendung in nahrungsmitteln
DE59504919D1 (de) Verfahren zur herstellung von ammonium-2-hydroxy-4-(methylthio)-butyrat und dieses enthaltende mischungen in flüssiger form und deren verwendung
DE69637737D1 (de) Polyesterzusammensetzung und daraus hergestellte folien
DE69411942T2 (de) Mehrschichtenmaterial und eine dieses material enthaltende anordnung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN